NCT02417974View on ClinicalTrials.gov

Prevention of Recurrence of Crohn's Disease by Fecal Microbiota Therapy (FMT)

PHASE2TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

February 4, 2021

Study Completion Date

February 4, 2021

Conditions
Crohn's Disease
Interventions
BIOLOGICAL

Fecal Microbiota Transplant (FMT)

Fecal Microbiota Transplant (FMT)

Trial Locations (2)

02118

Boston Medical Center, Boston

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors
All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Beth Israel Deaconess Medical Center

OTHER

collaborator

Massachusetts Institute of Technology

OTHER

lead

Boston Medical Center

OTHER